Decades of work, exponentially increased computing power and the availability and accessibility of enormous data sets is leading to dramatic changes and dramatic increases in drug discovery, improvements in clinical trial design and speed and
Tapping into the right key opinion leaders (KOLs) has long been the sales and marketing strategy for pharmaceutical companies. Even after a drug has been proven to be effective, doctors tend to be slow to
The separation between what is a biotechnology company and what is a pharmaceutical manufacturer has become less and less distinct. What is the difference between pharma and biotech? Why are we starting to use those
On August 12, 2022 Congress passed the Inflation Reduction Act which was heralded as finally addressing drug pricing for the American public. Why are American’s concerned about drug pricing and how does this Act address
In every prior recession of recent history, the early 1990s, the early 2000s and 2007-2009, the pharmaceutical industry has outperformed the market. In each of those time periods the U.S. national healthcare expenditure rose as
The inelastic demand for medicines is the primary reason pharma and biotech stocks usually outperform other industries in a recessionary market. Other areas of healthcare don’t do as well. Discretionary services like dental clinics and
